Jump to:
loading...| Preferred Name | abciximab | |
| Synonyms |
|
|
| ID |
http://www.ustb.edu.cn/thesauri/tocr/v1/data#C571352688529240170 |
|
| definition |
Abciximab (ReoPro) is the Fab fragment of a chimeric human/mouse monoclonal antibody directed against the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) receptor, the final mediator of aggregation. Abciximab appears to be safe when administered up to 24 hours after stroke onset, and it might improve functional outcome. |
|
| label |
abciximab |
|
| oboInOwl:hasDbXref | ||
| prefLabel |
abciximab |
|
| references |
Abciximab in Ischemic Stroke Investigators. (2000). Abciximab in Acute Ischemic Stroke A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study. Stroke, 31(3), 601-609. |
|
| subClassOf |
http://www.ustb.edu.cn/thesauri/tocr/v1/data#C571353432175145065 http://www.ustb.edu.cn/thesauri/tocr/v1/data#C571352688529240099 |
Create mapping